Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online September 11, 2007
Diabetes Care 30:3011-3016, 2007
DOI: 10.2337/dc07-1103
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
dc07-1103v1
30/12/3011    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shai, I.
Right arrow Articles by Stampfer, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shai, I.
Right arrow Articles by Stampfer, M. J.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Clinical Care/Education/Nutrition/Psychosocial Research
Original Research

Glycemic Effects of Moderate Alcohol Intake Among Patients With Type 2 Diabetes

A multicenter, randomized, clinical intervention trial

Iris Shai, RD, PHD1, Julio Wainstein, MD2, Ilana Harman-Boehm, MD3, Itamar Raz, MD4, Drora Fraser, PHD1, Assaf Rudich, MD, PHD5 and Meir J. Stampfer, MD, DRPH6

1 S. Daniel Abraham International Center for Health and Nutrition, Department of Epidemiology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
2 Diabetes Unit, Wolfson Medical Center, Holon, Israel
3 Department of Internal Medicine C and the Diabetes Unit, Soroka University Medical Center, Beer-Sheva, Israel
4 Diabetes Unit, Hadassah Hebrew University Medical Center, Jerusalem, Israel
5 S. Daniel Abraham International Center for Health and Nutrition, Department of Biochemistry, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
6 Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School and Departments of Epidemiology and Nutrition, Harvard School of Public Health, Boston, Massachusetts

Address correspondence and reprint requests to Iris Shai, RD, PhD, S. Daniel Abraham International Center for Health and Nutrition, Department of Epidemiology and Health Systems Evaluation, Ben-Gurion University of the Negev, P.O. Box 653, Beer-Sheva 84105, Israel. E-mail: irish{at}bgu.ac.il

OBJECTIVE—In a randomized controlled trial, we assessed the effect of daily moderate alcohol intake on glycemic control in the fasting and postprandial states in patients with type 2 diabetes who previously had abstained from alcohol.

RESEARCH DESIGN AND METHODS—We randomly assigned 109 patients (41–74 years old) with established type 2 diabetes who abstained from alcohol to receive 150 ml wine (13 g alcohol) or nonalcoholic diet beer (control) each day during a 3-month multicenter trial. The beverages were consumed during dinner. Diet and alcohol consumption were monitored.

RESULTS—During the intervention, 17% of participants (12% from the alcohol group) dropped out, leaving 91 who completed the trial. Within the alcohol group, fasting plasma glucose (FPG) decreased from 139.6 ± 41 to 118.0 ± 32.5 mg/dl after 3 months compared with 136.7 ± 15.4 to 138.6 ± 27.8 mg/dl in the control subjects (Pv = 0.015). However, alcohol consumption had no effect on 2-h postprandial glucose levels (difference of 18.5 mg/dl in the control group vs. 17.7 mg/dl in the alcohol group, Pv = 0.97). Patients in the alcohol group with higher baseline A1C levels had greater reductions in FPG (age-adjusted correlation –0.57, Pv < 0.001). No significant changes were observed in the levels of bilirubin, alkaline phosphatase, alanine aminotransferase, or aspartate aminotransferase, and no notable adverse effects were reported. Participants in the alcohol group reported an improvement in the ability to fall asleep (Pv < 0.001).

CONCLUSIONS—Among patients with type 2 diabetes who had previously abstained from alcohol, initiation of moderate daily alcohol consumption reduced FPG but not postprandial glucose. Patients with higher A1C may benefit more from the favorable glycemic effect of alcohol. Further intervention studies are needed to confirm the long-term effect of moderate alcohol intake.

Abbreviations: ALT, alanine aminotransferase • AST, aspartate aminotransferase • FPG, fasting plasma glucose


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
HeartHome page
R. Corder
Red wine, chocolate and vascular health: developing the evidence base
Heart, July 1, 2008; 94(7): 821 - 823.
[Full Text] [PDF]


Home page
JWatch GeneralHome page
Moderate Drinking Might Improve Fasting Glucose in People with Diabetes
Journal Watch (General), January 10, 2008; 2008(110): 1 - 1.
[Full Text]


Home page
JAMAHome page
E. L. Ding and F. B. Hu
Smoking and Type 2 Diabetes: Underrecognized Risks and Disease Burden
JAMA, December 12, 2007; 298(22): 2675 - 2676.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.